Matthew Mansh

Matthew Mansh practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Matthew Mansh's NPI, 1760879654, was assigned on April 20, 2015. Matthew Mansh graduated from Stanford University School Of Medicine in 2015. Matthew Mansh's Minnesota license number on file is 65551.

Matthew Mansh's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Matthew Mansh's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Matthew Mansh to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Mansh practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Matthew Mansh's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Matthew Mansh is board certified in dermatology by the American Board of Dermatology. Dmand AI has Matthew Mansh's licenses on file in 2 states: Minnesota and California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, psoriasis, rash and scalp rash among the conditions Matthew Mansh treats.

CMS data shows 3,245 Medicare services from Matthew Mansh across 16 procedure codes in 2024, for 575 Medicare patients. Medicare paid $141,877 for them.

CMS counts 575 Medicare patients who saw Matthew Mansh in 2024. The largest group is 65 to 74, with 267 patients. 66% of them have high cholesterol, and 62% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Matthew Mansh's median patient age at 63, with 50% women.

In 2024, Matthew Mansh wrote 1,487 Medicare Part D claims for 403 patients. 80% of them were for generic drugs. CMS names the drug for 1,286 of them, across 35 drugs with 11 or more claims each, at $1,273,760 in total drug cost. In 2023, CMS named 1,363 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Matthew Mansh for performance year 2024, reported as part of a group. Matthew Mansh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Matthew Mansh as offering telehealth. CMS counts 1,045 procedures of removal of skin lesions by Matthew Mansh, more than 93% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 46 papers to Matthew Mansh, published from 2013 to 2024. 2022 was the busiest year, with 6. The most frequent topics are Dermatology, Sexual and Gender Minorities and Sexual Behavior. Matthew Mansh has published most often in J Am Acad Dermatol. Matthew Mansh's most frequent co-authors are Ronda Samir Farah, MD, Sarah Tuttleton Arron, MD, PhD and Eleni Linos, MD.

Dmand AI links Matthew Mansh to 1 clinical trial. Conditions studied include Mpox, Monkeypox and Rodent Diseases.

Dmand AI lists 7 awards for Matthew Mansh, most recently Stanford Medical Scholar in 2015.

Matthew Mansh graduated from Stanford University School Of Medicine in 2015. Matthew Mansh is a member of Gay and Lesbian Dermatology Association.

Matthew Mansh is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.